Pre-treatment With Azithromycin to Reduce Immunogenicity to Anti-Tumor Necrosis Factor- α Agents in Patients With Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Diseases; Biological Substance; Adverse Effect Interventions: Drug: Azithromycin Pill; Other: Placebo Sponsor: Rambam Health Care Campus Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials